AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

OTCMKTS:QBIOQ BioMed Stock Price, Forecast & News

$1.89
+0.02 (+1.07 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.87
Now: $1.89
$1.91
50-Day Range
$1.72
MA: $1.97
$2.24
52-Week Range
$0.34
Now: $1.89
$3.75
Volume42,601 shs
Average Volume138,359 shs
Market Capitalization$42.63 million
P/E RatioN/A
Dividend YieldN/A
Beta2.59
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; BM-001 for the treatment of rare pediatric nonverbal autism spectrum disorder; and Uttroside-B for liver cancer. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was founded in 2013 and is based in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.65 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:QBIO
Previous SymbolNASDAQ:QBIO
CUSIPN/A
Phone212-588-0022

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.26) per share

Profitability

Net Income$-10,280,000.00

Miscellaneous

Employees1
Market Cap$42.63 million
Next Earnings Date7/16/2020 (Estimated)
OptionableNot Optionable

Receive QBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter.

Q BioMed (OTCMKTS:QBIO) Frequently Asked Questions

How has Q BioMed's stock been impacted by COVID-19 (Coronavirus)?

Q BioMed's stock was trading at $1.5728 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, QBIO shares have increased by 20.2% and is now trading at $1.89. View which stocks have been most impacted by Coronavirus.

When is Q BioMed's next earnings date?

Q BioMed is scheduled to release its next quarterly earnings announcement on Thursday, July 16th 2020. View our earnings forecast for Q BioMed.

How were Q BioMed's earnings last quarter?

Q BioMed Inc (OTCMKTS:QBIO) posted its quarterly earnings results on Monday, April, 13th. The company reported ($0.29) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.16) by $0.13. View Q BioMed's earnings history.

Has Q BioMed been receiving favorable news coverage?

Press coverage about QBIO stock has trended very negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Q BioMed earned a media sentiment score of -3.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutQ BioMed.

Who are some of Q BioMed's key competitors?

What other stocks do shareholders of Q BioMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Q BioMed investors own include Washington Trust Bancorp (WASH), Micron Technology (MU), NVIDIA (NVDA), Otonomy (OTIC), Canopy Growth (CGC), New Age Beverages (NBEV), Opko Health (OPK), Adobe (ADBE), Advanced Micro Devices (AMD) and Cyberark Software (CYBR).

Who are Q BioMed's key executives?

Q BioMed's management team includes the following people:
  • Mr. Denis D. Corin, Chairman, CEO, Pres & CFO (Age 46)
  • Mr. William S. Rosenstadt, Gen. Counsel & Director (Age 51)
  • Mr. David Laskow-Pooley, VP of Product Devel. (Age 65)
  • Mr. Robert Derham, VP of Orphan Products
  • Mr. Ari Jatwes, Bus. Devel. Analyst

What is Q BioMed's stock symbol?

Q BioMed trades on the OTCMKTS under the ticker symbol "QBIO."

How do I buy shares of Q BioMed?

Shares of QBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Q BioMed's stock price today?

One share of QBIO stock can currently be purchased for approximately $1.89.

How big of a company is Q BioMed?

Q BioMed has a market capitalization of $42.63 million. Q BioMed employs 1 workers across the globe.

What is Q BioMed's official website?

The official website for Q BioMed is www.qbiomed.com.

How can I contact Q BioMed?

Q BioMed's mailing address is 366 MADISON AVENUE 3RD FLOOR, NEW YORK NY, 10017. The company can be reached via phone at 212-588-0022.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.